2019
DOI: 10.1208/s12249-019-1316-0
|View full text |Cite
|
Sign up to set email alerts
|

Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(9 citation statements)
references
References 59 publications
0
9
0
Order By: Relevance
“…Coencapsulation of PTX and ceramide decreased the concentration necessary to reduce cell viability by 2.5-4.5-fold to 50% (EC 50 ), indicating a synergistic effect [332]. In other studies, codelivery of ceramide and DOX through lipid nanocarriers was effective in enhancing the antitumor efficacy of DOX in vitro and in murine melanoma models [333,334]. reported an antitumor efficacy of 93.94 ± 2.77% for a multifunctional nanocarrier, a finding that was significantly higher than that of a single drug-loaded nanocarrier and the Duopafei® control [334].…”
Section: Multifunctional Delivery Systemsmentioning
confidence: 87%
“…Coencapsulation of PTX and ceramide decreased the concentration necessary to reduce cell viability by 2.5-4.5-fold to 50% (EC 50 ), indicating a synergistic effect [332]. In other studies, codelivery of ceramide and DOX through lipid nanocarriers was effective in enhancing the antitumor efficacy of DOX in vitro and in murine melanoma models [333,334]. reported an antitumor efficacy of 93.94 ± 2.77% for a multifunctional nanocarrier, a finding that was significantly higher than that of a single drug-loaded nanocarrier and the Duopafei® control [334].…”
Section: Multifunctional Delivery Systemsmentioning
confidence: 87%
“…Due to the high toxicity of conventional chemotherapeutic agents and poor drug delivery, nanomedicines have emerged as a novel tool to improve cancer treatment. Based on the drug's physicochemical properties, nano‐formulations with improved stability, greater circulation half‐lives, enhanced intratumor deposition, and controlled release can be achieved 31‐33 . These properties can be optimized to improve antitumor activity and reduce toxicity to nontarget, healthy tissues 34,35 .…”
Section: Nanotechnology For Delivery Of Resveratrolmentioning
confidence: 99%
“…The size-dependent coupling of graphene nanosheets with DNA molecules was reported that GQDs have a limited lateral dimension and the capacity of DNA molecules to intercalate is most apparent. Moreover, Doxorubicin (DOX) is a frequently used therapeutic agent for human cancers such as sarcoma of the soft tissue, aggressive non-Hodgkin's lymphoma, and breast cancer [170]. The targeted drug binds to the GQDs functional groups and the drug is loaded onto the surface through the π-π interaction for precise DOX delivery into tumor cells.…”
Section: Drug Delivery Formulating Systemsmentioning
confidence: 99%